Stratedigm, Inc.
San Jose, CA
- UEI
- L3DTEH5JZ4A9
- CAGE
- 4X7H0
- Primary NAICS
- 334516 Analytical Laboratory Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 911 Bern Ct Suite 100, San Jose, CA 95112, USA
- Website
- stratedigm.com
- Founded
- 2004
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 38 Instruments & Related Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $39,898 |
| FY2024 | $39,898 |
| FY2023 | $54,473 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Kinetic River Corp. | Mountain View, CA | 334516 Analytical Laboratory Instrument Manufacturing |
| Cytek Biosciences, Inc. | Fremont, CA | 334516 Analytical Laboratory Instrument Manufacturing |
| Sony Corp Of America | — | 334516 Analytical Laboratory Instrument Manufacturing |
| BD Biosciences | Milpitas, CA | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Lase Innovation Inc. | Waltham, MA | 334516 Analytical Laboratory Instrument Manufacturing |
About the company
Stratedigm, Inc. is a manufacturer of configurable, scalable, and upgradeable benchtop flow cytometry systems. The company provides flow cytometers and preventative maintenance services to the Department of Health and Human Services, including the Food and Drug Administration and Centers for Disease Control and Prevention.
Stratedigm has received over $499,000 in federal contracts from HHS since 2019, all of which were prime contracts with no set-aside designation. These include purchase orders for upgrades to an existing flow cytometry system to enable 24-color parameter measurement, multi-year preventative maintenance service agreements for existing equipment, and other supporting functions. Specific services provided comprise hardware upgrades, maintenance services, and ancillary support for Stratedigm's proprietary flow cytometry products used by HHS laboratories and research facilities.
SBA capabilities narrative
Stratedigm is the leader in scalable flow cytometry analyzers with world-class automation, industry-leading sensitivity, resolution, and performance. Customizable to grow with the customer's needs and upgradeable to utilize the latest technological advances, our future-proof products distinguish themselves by having both the smallest footprint in their class and offering an immaculately integrated automation suite.
Quick answers
Is Stratedigm, Inc. registered in SAM.gov?
Yes. Stratedigm, Inc.'s SAM.gov registration is active through November 26, 2026.
How much has Stratedigm, Inc. received in federal contracts?
Federal contracts obligated $39,898 to Stratedigm, Inc. in fiscal year 2025 and $134,269 in fiscal years 2023 through 2027.
What is Stratedigm, Inc.'s most recent federal award?
Stratedigm, Inc.'s most recent federal contract award is Preventative maintenance service contract for existing sratedigm S1000 flow cytometry system (75F40121P00330), from Food and Drug Administration, on July 13, 2021.
On GovTribe
See Stratedigm, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors